Clinical Trials · NCT01056549
Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University Health Network, Toronto
- Enrollment
- 15
- Start date
- Jan 2010
- Locations
- 1 site, Canada
- Primary endpoint
- The objective is to examine the change in apoB48 production rate after one subcutaneous injection of exenatide, under conditions of a pancreatic clamp and a steady state fed state.